- Home
- HITI vs MDWD Comparison
HITI vs MDWD Comparison
Compare HITI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- MDWD
- Stock Information
- Founded
- HITI 2009
- MDWD 2000
- Country
- HITI Canada
- MDWD Israel
- Employees
- HITI N/A
- MDWD N/A
- Industry
- HITI
- MDWD Medicinal Chemicals and Botanical Products
- Sector
- HITI
- MDWD Health Care
- Exchange
- HITI Nasdaq
- MDWD Nasdaq
- Market Cap
- HITI 188.0M
- MDWD 184.8M
- IPO Year
- HITI N/A
- MDWD 2014
- Fundamental
- Price
- HITI $3.07
- MDWD $18.29
- Analyst Decision
- HITI Strong Buy
- MDWD Strong Buy
- Analyst Count
- HITI 1
- MDWD 1
- Target Price
- HITI $4.50
- MDWD $25.00
- AVG Volume (30 Days)
- HITI 631.4K
- MDWD 59.3K
- Earning Date
- HITI 01-27-2025
- MDWD 11-26-2024
- Dividend Yield
- HITI N/A
- MDWD N/A
- EPS Growth
- HITI N/A
- MDWD N/A
- EPS
- HITI N/A
- MDWD N/A
- Revenue
- HITI $370,017,302.00
- MDWD $19,720,000.00
- Revenue This Year
- HITI $7.52
- MDWD $10.37
- Revenue Next Year
- HITI $14.03
- MDWD $26.36
- P/E Ratio
- HITI N/A
- MDWD N/A
- Revenue Growth
- HITI 9.02
- MDWD N/A
- 52 Week Low
- HITI $1.57
- MDWD $11.04
- 52 Week High
- HITI $3.62
- MDWD $24.00
- Technical
- Relative Strength Index (RSI)
- HITI 47.65
- MDWD 57.26
- Support Level
- HITI $2.91
- MDWD $15.80
- Resistance Level
- HITI $3.47
- MDWD $18.25
- Average True Range (ATR)
- HITI 0.16
- MDWD 0.84
- MACD
- HITI -0.02
- MDWD -0.03
- Stochastic Oscillator
- HITI 29.82
- MDWD 95.77
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.